Biotech | November 20, 2021
Oravax and Genomma JV to commercialise Covid-19 vaccine in Mexico and Latam
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
The initiative will engage adolescents and youth of India in decisions about their reproductive health
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
Invisible Nation is a worldwide network of patient organizations committed to driving a decline in cardiovascular (CV) death by effecting systemic change in atherosclerotic cardiovascular disease (ASCVD) care
The company proposes to invest up to US $ 50 million, over a period of five years, starting from FY22, to support capability development of talent and technology
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
The initiative will create an integrated network of Critical Care Units (CCUs) across the Apollo Hospitals network but also in partnership with non-Apollo units in India and overseas
Subscribe To Our Newsletter & Stay Updated
